Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study was an ambispective observational cohort study that included sepsis patients hospitalized in the Intensive care unit (ICU) of the Nankai Hospital. All patients met the consensus criteria of sepsis-3. The purpose of this study is to investigate the valuable biomarkers for the severity of sepsis and predictors of 30-day mortality for patients with sepsis.
All patients met the consensus criteria of sepsis-3. The purpose of this study is to investigate the valuable biomarkers for the severity of sepsis and predictors of 30-day mortality for patients with sepsis.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sepsis | disease |
| |
| Healthy controls | healthy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| nothing | Other | disease |
|
| Measure | Description | Time Frame |
|---|---|---|
| cAMP-response element binding protein 3, CREB3 | CREB3 levels were measured in the PBMCs of sepsis patients and healthy controls | Up to Day 28 |
| ADP-ribosylation factor 4, ARF4 | ARF4 levels were measured in the PBMCs of sepsis patients and healthy controls | Up to Day 28 |
| Measure | Description | Time Frame |
|---|---|---|
| Heme oxygnase-1, HO-1 | HO-1 levels were measured in the PBMCs of sepsis patients and healthy controls | Up to Day 28 |
| ARF family | ARF1, ARF3, ARF5, ARF6 levels were measured in the PBMCs of sepsis patients and healthy controls |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Septic patients and healthy controls
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jianbo Yu, MD | Contact | +8615344422323 | 30717008@nankai.edu.cn |
| Name | Affiliation | Role |
|---|---|---|
| Jianbo Yu, MD | Tianjin Nankai Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Tianjin Nankai Hospital | Recruiting | Tianjin | Tianjin Municipality | 300000 | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 31573637 | Background | Fowler AA 3rd, Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, Fisher B, Thacker LR 2nd, Natarajan R, Brophy DF, Sculthorpe R, Nanchal R, Syed A, Sturgill J, Martin GS, Sevransky J, Kashiouris M, Hamman S, Egan KF, Hastings A, Spencer W, Tench S, Mehkri O, Bindas J, Duggal A, Graf J, Zellner S, Yanny L, McPolin C, Hollrith T, Kramer D, Ojielo C, Damm T, Cassity E, Wieliczko A, Halquist M. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial. JAMA. 2019 Oct 1;322(13):1261-1270. doi: 10.1001/jama.2019.11825. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D018805 | Sepsis |
| ID | Term |
|---|---|
| D007239 | Infections |
| D018746 | Systemic Inflammatory Response Syndrome |
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
The peripheral blood mononuclear cells (PBMCs) were acquired from blood by a density gradient centrifugation method (Ficoll Histopaque); peripheral blood of normal subjects and septic cases.
| Up to Day 28 |
| Oxygenation index | The ratio of arterial oxygen partial pressure (PaO2 in mmHg) to fractional inspired oxygen (FiO2 expressed as a fraction, not a percentage). | Up to Day 28 |
| Mechanical ventilation days | The number of days the patient was alive and mechanical ventilating | Up to Day 28 |
| Inflammation biomarkers Inflammation levels | Procalcitonin (PCT), C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6) | Up to Day 28 |
| ICU stay length | The number of days the patient was alive and ICU stay | Up to Day 90 |
| 28 days survive | All Cause Mortality to Day 28 | Up to Day 28 |
| Sequential Organ-Failure Assessment (SOFA) score | The SOFA score is used to assess the severity and prognosis of sepsis. SOFA was based on six different scores, one for each of the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems each scored from 0 to 4 with an increasing score reflecting worsening organ dysfunction. | Up to Day 28 |
| Acute Physiology and Chronic Health Evaluation II (APACHE II) score | The APACHE II score consists of three parts: acute physiological score, age score, and chronic health score. APACHE II uses a point score (range 0 to 71) based upon initial values of 12 routine physiologic measurements, age, and previous health status to provide a general measure of severity of disease, with an increasing score reflecting worsening organ dysfunction. | Up to Day 28 |
| D013568 |
| Pathological Conditions, Signs and Symptoms |